BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3428 related articles for article (PubMed ID: 7597290)

  • 21. Is DNA ploidy of prognostic significance in stage I cutaneous melanoma?
    Gattuso P; Reddy V; Solans E; Kathuria S; Aranha GV; Jacobs HK; Walloch J
    Surgery; 1990 Oct; 108(4):702-8; discussion 708-9. PubMed ID: 2218882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation between lymphomas and pseudolymphomas of the skin by computerized DNA-image cytometry.
    Stolz W; Vogt T; Braun-Falco O; Abmayr W; Eckert F; Kaudewitz P; Vieluf D; Bieber K; Burg G
    J Invest Dermatol; 1990 Feb; 94(2):254-60. PubMed ID: 2405067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA-ploidy abnormalities are a reflection of the metastatic potential of malignant melanoma. Microfluorometric DNA analysis.
    Umebayashi Y; Otsuka F
    Acta Derm Venereol; 1997 Mar; 77(2):118-21. PubMed ID: 9111821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA ploidy-characteristics of human malignant melanoma analysed by flow cytometry and compared with histology and clinical course.
    Søndergaard K; Larsen JK; Møller U; Christensen IJ; Hou-Jensen K
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1983; 42(1):43-52. PubMed ID: 6132488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance in malignant melanoma of nuclear DNA content measured by a microfluorimetric method.
    Umebayashi Y; Otsuka F
    Arch Dermatol Res; 1995; 287(8):718-22. PubMed ID: 8554382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relations between various DNA-parameters and degree of malignancy in endometrial carcinoma.
    Naumann G; Köhler U; Nenning H; Emmert C; Taubert G; Bilek K
    Arch Gynecol Obstet; 1996; 258(3):113-7. PubMed ID: 8781698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discrimination between benign and malignant melanocytic skin lesions by multivariate analysis, quantitative S-100 immunohistochemistry, nuclear morphometry and DNA cytometry.
    Williams RA; Rode J; Baak JP; Charlton IG
    Anal Quant Cytol Histol; 1999 Aug; 21(4):353-7. PubMed ID: 10560514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical expression of p53 protein, mitotic index and nuclear morphometry in primary malignant melanoma of the skin.
    Talve L; Kainu J; Collan Y; Ekfors T
    Pathol Res Pract; 1996 Aug; 192(8):825-33. PubMed ID: 8897518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometric analysis of uterine sarcoma: ploidy and S-phase rate as prognostic indicators.
    Malmström H; Schmidt H; Persson PG; Carstensen J; Nordenskjöld B; Simonsen E
    Gynecol Oncol; 1992 Feb; 44(2):172-7. PubMed ID: 1544595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow DNA-cytometric findings of paraffin-embedded primary cutaneous melanomas related to prognosis.
    Lindholm C; Hofer PA; Jonsson H; Tribukait B
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 58(2):147-51. PubMed ID: 2575819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA ploidy status in 84 ocular melanomas: a study of DNA quantitation in ocular melanomas by flow cytometry and automatic and interactive static image analysis.
    Coleman K; Baak JP; van Diest PJ; Curran B; Mullaney J; Fenton M; Leader M
    Hum Pathol; 1995 Jan; 26(1):99-105. PubMed ID: 7821923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of morphometry and DNA flow-cytometry features of invasive breast cancers detected by population screening: comparison with control group of hospital patients.
    Uyterlinde AM; Baak JP; Schipper NW; Peterse HJ; Meijer JW; Vooys PG; Matze E
    Int J Cancer; 1991 May; 48(2):173-81. PubMed ID: 2019464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small malignant melanomas: clinicopathologic correlation and DNA ploidy analysis.
    Kamino H; Kiryu H; Ratech H
    J Am Acad Dermatol; 1990 Jun; 22(6 Pt 1):1032-8. PubMed ID: 2370327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of DNA image cytometry in Libyan breast cancer.
    Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y
    Oncology; 2012; 83(3):165-76. PubMed ID: 22906963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative DNA and morphometric analysis of gastroscopic brush smears by TV image analysis.
    Molnár B; Szaleczky E; Prónai L; Papik K; Zágoni T; Tulassay Z
    Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):103-9. PubMed ID: 10656219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma in situ (MIS) adjacent to an invasive nodular melanoma ("SSM/NM") and its metastases--DNA-cytophotometry, mitotic index, and anisokaryosis.
    Schmiegelow P; Oppermann T; Nüssgen A; Schroiff R; Jänner M; Breitbart EW
    Virchows Arch A Pathol Anat Histopathol; 1987; 411(3):213-21. PubMed ID: 3113063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Image cytometric DNA analysis in transitional cell carcinoma of the bladder.
    Schapers RF; Ploem-Zaaijer JJ; Pauwels RP; Smeets AW; van den Brandt PA; Tanke HJ; Bosman FT
    Cancer; 1993 Jul; 72(1):182-9. PubMed ID: 8508404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA flow cytometry in the prognosis of primary malignant melanoma.
    Bartkowiak D; Schumann J; Otto FJ; Lippold A; Drepper H
    Oncology; 1991; 48(1):39-43. PubMed ID: 1987497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow cytometry and prognostic implications in patients with solid tumors.
    Williams NN; Daly JM
    Surg Gynecol Obstet; 1990 Sep; 171(3):257-66. PubMed ID: 2201096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 172.